Krishna Vaddi
2022
In 2022, Krishna Vaddi earned a total compensation of $3.3M as Chief Executive Officer at Prelude Therapeutics, a 53% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $238,425 |
|---|---|
| Option Awards | $2,498,244 |
| Salary | $558,333 |
| Other | $9,150 |
| Total | $3,304,152 |
Vaddi received $2.5M in option awards, accounting for 76% of the total pay in 2022.
Vaddi also received $238.4K in non-equity incentive plan, $558.3K in salary and $9.2K in other compensation.
Rankings
In 2022, Krishna Vaddi's compensation ranked 1,099th out of 5,760 executives tracked by ExecPay. In other words, Vaddi earned more than 80.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,099 out of 5,760 | 81st |
Division Manufacturing | 523 out of 3,136 | 83rd |
Major group Chemicals And Allied Products | 191 out of 1,422 | 87th |
Industry group Drugs | 172 out of 1,323 | 87th |
Industry Pharmaceutical Preparations | 130 out of 969 | 87th |
Source: SEC filing on April 28, 2023.
Vaddi's colleagues
We found two more compensation records of executives who worked with Krishna Vaddi at Prelude Therapeutics in 2022.